Publications by authors named "Geoffrey Farrell"

Claim this Profile
C
Corrigendum to "CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis" [J Hepatol (2014) 61:1365-75].
Xiang Zhang, Jiayun Shen, Kwan Man, Eagle S H Chu, Tung On Yau, Geoffrey Farrell

J Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across Australia.
Dao Sen Wang, Amy Phu, Kristen McKee, Simone I Strasser, Sinead Sheils, Geoffrey C Farrell

Open Forum Infect Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Cholesterol-Associated Steatohepatitis in the Development of NASH.
Christian L Horn, Amilcar L Morales, Christopher Savard, Geoffrey C Farrell, George N Ioannou

Hepatol Commun· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics.
Timothy Papaluca, Stuart K Roberts, Simone I Strasser, Katherine A Stuart, Geoffrey Farrell

Clin Infect Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-alcoholic fatty liver disease: Not time for an obituary just yet!
Shivaram Prasad Singh, Prajna Anirvan, K Rajender Reddy, Hari S Conjeevaram, Giulio Marchesini, Geoffrey C Farrell

J Hepatol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exercise retards hepatocarcinogenesis in obese mice independently of weight control.
Arfianti Arfianti, Sharon Pok, Vanessa Barn, W Geoffrey Haigh, Matthew M Yeh, Geoffrey C Farrell

J Hepatol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusion.
Rowan F van Golen, Megan J Reiniers, Gerben Marsman, Lindy K Alles, Derrick M van Rooyen, Geoffrey C Farrell

Biochim Biophys Acta Mol Basis Dis· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Associated With Human Nonalcoholic Steatohepatitis.
George N Ioannou, Charles S Landis, Ga-Young Jin, W Geoffrey Haigh, Geoffrey C Farrell

Hepatol Commun· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-alcoholic fatty liver disease.
Geoffrey C Farrell, Rebecca Wardell, Narci Teoh, Shiv Chitturi

Intern Med J· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications.
Sze Pheh Yeap, Hugh Harley, Richard Thompson, Kate Diana Williamson, John Bate, Geoffrey Farrell

J Gastroenterol Hepatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of brown adipose tissue enhances the efficacy of caloric restriction for treatment of nonalcoholic steatohepatitis.
Laurence Poekes, Justine Gillard, Geoffrey C Farrell, Yves Horsmans, Isabelle A Leclercq

Lab Invest· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
Geoffrey C Farrell, Fahrettin Haczeyni, Shivakumar Chitturi

Adv Exp Med Biol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling.
Jessie Qiaoyi Liang, Narcissus Teoh, Lixia Xu, Sharon Pok, Xiangchun Li, Geoffrey Farrell

Nat Commun· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mouse models of non-alcoholic steatohepatitis: A reflection on recent literature.
Fahrettin Haczeyni, Matthew M Yeh, George N Ioannou, Isabelle A Leclercq, Robert Goldin, Geoffrey C Farrell

J Gastroenterol Hepatol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis.
Scott L Friedman, Vlad Ratziu, Stephen A Harrison, Manal F Abdelmalek, Guruprasad P Aithal, Geoffrey Farrell

Hepatology· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis.
Lianne de Haan, Sarah J van der Lely, Anne-Loes K Warps, Quincy Hofsink, Pim B Olthof, Geoffrey C Farrell

J Clin Transl Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Fate of Human Fetal Liver Progenitor Cells Transplanted in Injured Mouse Livers.
Antony Irudayaswamy, Mark Muthiah, Lei Zhou, Hau Hung, Nur Halisah Bte Jumat, Geoffrey Farrell

Stem Cells· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice.
Fahrettin Haczeyni, Hans Wang, Vanessa Barn, Auvro R Mridha, Matthew M Yeh, Geoffrey C Farrell

Hepatol Commun· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
Auvro R Mridha, Fahrettin Haczeyni, Matthew M Yeh, W Geoffrey Haigh, George N Ioannou, Geoffrey C Farrell

Clin Sci (Lond)· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deriving and testing of dysplastic murine hepatocytes: A new platform in liver cancer research.
Sharon Pok, Harpreet Vohra, Charbel Wehbe, Vanessa A Barn, Evi Arfianti, Geoffrey C Farrell

Exp Cell Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH.
George N Ioannou, Savitha Subramanian, Alan Chait, W Geoffrey Haigh, Matthew M Yeh, Geoffrey C Farrell

J Lipid Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
Auvro R Mridha, Alexander Wree, Avril A B Robertson, Matthew M Yeh, Casey D Johnson, Geoffrey C Farrell

J Hepatol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defective adaptive thermogenesis contributes to metabolic syndrome and liver steatosis in obese mice.
Laurence Poekes, Vanessa Legry, Olivier Schakman, Christine Detrembleur, Anne Bol, Geoffrey C Farrell

Clin Sci (Lond)· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice.
Fahrettin Haczeyni, Laurence Poekes, Hans Wang, Auvro R Mridha, Vanessa Barn, Geoffrey C Farrell

Obesity (Silver Spring)· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenesis and novel treatment options for non-alcoholic steatohepatitis.
Vincent Wai-Sun Wong, Shiv Chitturi, Grace Lai-Hung Wong, Jun Yu, Henry Lik-Yuen Chan, Geoffrey C Farrell

Lancet Gastroenterol Hepatol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis